Retained Earnings (Accumulated Deficit) in USD of WINDTREE THERAPEUTICS INC /DE/ from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
WINDTREE THERAPEUTICS INC /DE/ quarterly Retained Earnings (Accumulated Deficit) history and change rate from Q4 2010 to Q3 2025.
  • WINDTREE THERAPEUTICS INC /DE/ Retained Earnings (Accumulated Deficit) for the quarter ending 30 Sep 2025 was $889,371,000, a 4.8% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $889,371,000 -$40,565,000 -4.8% 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $861,286,000 -$14,658,000 -1.7% 30 Jun 2025 10-Q 19 Aug 2025 2025 Q2
Q1 2025 $850,655,000 -$16,051,000 -1.9% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $846,610,000 -$1,787,000 -0.21% 31 Dec 2024 10-Q 19 Nov 2025 2025 Q3
Q3 2024 $848,806,000 -$9,137,000 -1.1% 30 Sep 2024 10-Q 26 Nov 2024 2024 Q3
Q2 2024 $846,628,000 -$11,384,000 -1.4% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 $834,604,000 -$5,961,000 -0.72% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $844,823,000 -$20,291,000 -2.5% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $839,669,000 -$24,829,000 -3% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $835,244,000 -$24,460,000 -3% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $828,643,000 -$35,192,000 -4.4% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $824,532,000 -$39,208,000 -5% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 $814,840,000 -$42,589,000 -5.5% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $810,784,000 -$46,746,000 -6.1% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $793,451,000 -$66,802,000 -9.2% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $785,324,000 -$67,636,000 -9.4% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $772,251,000 -$62,017,000 -8.7% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $764,038,000 -$62,824,000 -9% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $726,649,000 -$34,993,000 -5.1% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $717,688,000 -$32,566,000 -4.8% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $710,234,000 -$32,487,000 -4.8% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $701,214,000 -$30,593,000 -4.6% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $691,656,000 -$27,472,000 -4.1% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 $685,122,000 -$27,475,000 -4.2% 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q3 2019 $677,747,000 -$29,142,000 -4.5% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $670,621,000 -$25,943,000 -4% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $664,184,000 -$22,558,000 -3.5% 31 Mar 2019 10-Q 20 May 2019 2019 Q1
Q4 2018 $657,647,000 -$20,533,000 -3.2% 31 Dec 2018 10-K 03 Apr 2020 2019 FY
Q3 2018 $648,605,000 -$9,018,000 -1.4% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 $644,678,000 -$10,534,000 -1.7% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 $641,626,000 -$14,234,000 -2.3% 31 Mar 2018 10-Q 21 May 2018 2018 Q1
Q4 2017 $637,114,000 -$18,446,000 -3% 31 Dec 2017 10-K/A 23 Apr 2019 2018 FY
Q3 2017 $639,587,000 -$27,521,000 -4.5% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 $634,144,000 -$30,441,000 -5% 30 Jun 2017 10-Q 21 Aug 2017 2017 Q2
Q1 2017 $627,392,000 -$34,313,000 -5.8% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $618,668,000 -$39,490,000 -6.8% 31 Dec 2016 10-K 17 Apr 2018 2017 FY
Q3 2016 $612,066,000 -$42,997,000 -7.6% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 $603,703,000 -$56,190,000 -10% 30 Jun 2016 10-Q 10 Aug 2016 2016 Q2
Q1 2016 $593,079,000 -$56,892,000 -11% 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 $579,178,000 -$55,170,000 -11% 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 $569,069,000 -$55,696,000 -11% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $547,513,000 -$45,464,000 -9.1% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 $536,187,000 -$44,761,000 -9.1% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 $524,008,000 -$44,058,000 -9.2% 31 Dec 2014 10-K 29 Mar 2016 2015 FY
Q3 2014 $513,373,000 -$45,152,000 -9.6% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 $502,049,000 -$46,051,000 -10% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 $491,426,000 -$44,055,000 -9.8% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 $479,950,000 -$45,215,000 -10% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 $468,221,000 -$40,301,000 -9.4% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 $455,998,000 -$41,424,000 -10% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 $447,371,000 -$39,935,000 -9.8% 31 Mar 2013 10-Q 07 May 2013 2013 Q1
Q4 2012 $434,735,000 -$37,315,000 -9.4% 31 Dec 2012 10-K 17 Mar 2014 2013 FY
Q3 2012 $427,920,000 -$34,801,000 -8.9% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 $414,574,000 -$26,206,000 -6.7% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 $407,436,000 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 $397,420,000 -$20,965,000 -5.6% 31 Dec 2011 10-K 15 Mar 2013 2012 FY
Q3 2011 $393,119,000 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 $388,368,000 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 $376,455,000 31 Dec 2010 10-K 30 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.